"Work commenced on dossier preparation for FDA regulatory clearance for the Company’s new Artificial Intelligence tool for the automated assessment of liver fat. The Company intends to submit its dossier in the March 2020 quarter."
The new submission for FDA approval relating to AI assessment of liver fat, is not far away.
Ann: Half Yearly Report and Accounts, page-6
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.36M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 87965 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 158730 | 1 |
View Market Depth
| Last trade - 16.12pm 05/09/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable